Page 1290 - Equine Clinical Medicine, Surgery and Reproduction, 2nd Edition
P. 1290

Skin                                          1265



  VetBooks.ir    • Podophyllin 50% applied daily for >30 days.  owners in 75% of cases and a decrease in the size
             • 10% arsenic trioxide in aqueous solution for
                                                         of sarcoids in 93.8% of cases. Clinical regression,
            5 days. Causes heavy crust formation, which
            may be difficult to remove.                  observed  by  owners,  was  noted  in  68.8%  of  cases.
                                                         There were complications in 43.8% of cases and
             • AW–LUDES (Liverpool University            owner satisfaction in 75% of cases.
            Department of Equine Surgery), a topical
            proprietary ointment containing a variety of   Surgery
            heavy metals, rosemary oil and antimitotic   Removal of the sarcoid, plus at least a 15–20 mm ring
            compounds such as 5-fluorouracil and         of normal tissue, is performed using traditional or
            thiouracil, administered on successive or    CO  laser surgical techniques, under local or general
                                                            2
            alternate days for 3–5 treatments. Within    anaesthetic. The disadvantages are: 50% may recur;
            5–10 weeks preferential necrosis and sloughing   as the wound heals sarcoids may spread to other areas
            of the sarcoid tissues should be noted with   on the horse; removal of large areas of normal skin
            35–80% complete regression. This treatment is   precludes closure and slows healing time; inability
            not recommended for use around the eyes, on   to remove this quantity of skin from limb lesions
            distal limbs or on coronary bands.           increases the risk of recurrence.
             • Imiquimod 5% topical cream applied every other
            day stimulates Tol-like receptor-7, inducing a   Electrocautery
            Th1 cytokine local immune response (IL-2,    Where  single small masses are  involved,  ordi-
            IL-12, IFN-alpha and -gamma) as well as an   nary cautery is satisfactory, but recurrence can be
            increase of TNF-α, IL-1, IL-6 and IL-8.      expected. Large electrocautery units use a cutting
             • XXterra , a caustic agent containing zinc   current to remove the sarcoid, then treat the area,
                   ®
            chloride and bloodroot (Sanguineria canadensis),   particularly the skin edges, with fulguration to des-
            which is rich in alkaloids and applied daily for   iccate the tissue.
            4–6 days, then every 4th day until resolved.
            Bloodroot is proposed to alter the tumour    Cryosurgery
            antigens of sarcoids in vivo, apparently     This is useful for sarcoids, but depends on correct
            stimulating the immune system to recognise   technique.  Complications  are  under-  or  overtreat-
            them as foreign and mount a response quite   ment and injury to surrounding blood vessels, nerves,
            similar to the host versus graft reaction.   bone and tendon. Leucoderma and leucotrichia may
                                                         occur at the treated site.
          Vaccination or stimulation of the immune system
          Bovine wart vaccine has been found to be valueless.   Radiation therapy
          Pox vaccines injected into the sarcoid lesion were   Can use either a large, distant irradiating source
          also unsuccessful. Autogenous vaccines have been   ( teletherapy), which restricts its use to a   limited
          manufactured, but results have not been good, with   number of large facilities, or treatment with
          recovery  in  <25%  of  animals  treated.  Intralesional   implants or isotopes applied to or within the tumour
          bacillus Calmette–Guérin (BCG) therapy has been   (brachytherapy), which is more practical for equine
          successful, particularly for eyelid lesions. In 2008, an   treatment. SCCs, sarcoids, soft-tissue sarcomas
          autologous vaccination procedure was reported that   (fibrosarcomas, haemangiosarcomas and neurofi-
          utilised sarcoid tissue frozen in liquid nitrogen and   bromas), cutaneous lymphomas and melanomas are
          subsequently implanted into subcutaneous pockets   suitable for this mode of treatment.
          in the neck. Complete tumour regression was noted   The advantages include less disfigurement and
          in 12 of 15 cases. In 2015, a retrospective case series   better therapeutic success and it is the best choice for
          of 18 horses at the University of Pennsylvania’s New   follow-up after failed surgery, cryosurgery or immu-
          Bolton Center reported that the technique resulted   notherapy. Optimum results come from its application
          in a decrease in the number of lesions observed by   following debulking surgery under general anaesthesia.
   1285   1286   1287   1288   1289   1290   1291   1292   1293   1294   1295